Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Marschner

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Geriatric Oncology|May 27, 2019
Efficacy of immune checkpoint inhibitors in older adults with advanced stage cancers: A meta-analysisLawrence Kasherman, Derrick Ho Wai Siu, Kirsty Wai Chung Lee, et al.
Future Oncology (London, England)|February 14, 2022
PD-L1 expression as a prognostic marker in patients treated with chemotherapy for metastatic non-small-cell lung cancerRachel Woodford, Deborah Zhou, Sarah J Lord, et al.
Acta Oncologica (Stockholm, Sweden)|September 26, 2019
The impact of smoking on the effectiveness of immune checkpoint inhibitors - a systematic review and meta-analysisKirsty Wai Chung Lee, Sarah J Lord, Lawrence Kasherman, et al.
Future Oncology (London, England)|July 30, 2019
Predictive value of PD-L1 and other clinical factors for chemoimmunotherapy in advanced non-small-cell lung cancerRachel Woodford, Yanni Loh, Joanna Lee, et al.
Journal of the American Heart Association|February 18, 2022
Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID StudyMalcolm West, Adrienne Kirby, Ralph A Stewart, et al.
Journal of the American Heart Association|October 25, 2024
Plasma Protein Biomarkers and Long-Term Cardiovascular Mortality Risk in Patients With Chronic Coronary Heart DiseaseRalph A H Stewart, Kristy P Robledo, Andrew M Tonkin, et al.
BMJ Paediatrics Open|February 12, 2025
Targeted oxygenation in the respiratory care of premature infants at delivery-effects on outcome: a randomised controlled trial (Torpido 3060) study protocolJu Lee Oei, Javeed Travadi, Adrienne Kirby, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 28, 2018
The Value of Early Depth of Response in Predicting Long-Term Outcome in EGFR-Mutant Lung CancerChee Khoon Lee, Sally Lord, Ian Marschner, et al.
Diabetes, Obesity & Metabolism|April 4, 2020
Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD studyJacob Y Cao, Boris Waldman, Rachel O'Connell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Serum Human Epidermal Growth Factor 2 Extracellular Domain as a Predictive Biomarker for Lapatinib Treatment Efficacy in Patients With Advanced Breast CancerChee Khoon Lee, Lucy Davies, Val J Gebski, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Geriatric Oncology|May 27, 2019
Efficacy of immune checkpoint inhibitors in older adults with advanced stage cancers: A meta-analysisLawrence Kasherman, Derrick Ho Wai Siu, Kirsty Wai Chung Lee, et al.
Future Oncology (London, England)|February 14, 2022
PD-L1 expression as a prognostic marker in patients treated with chemotherapy for metastatic non-small-cell lung cancerRachel Woodford, Deborah Zhou, Sarah J Lord, et al.
Acta Oncologica (Stockholm, Sweden)|September 26, 2019
The impact of smoking on the effectiveness of immune checkpoint inhibitors - a systematic review and meta-analysisKirsty Wai Chung Lee, Sarah J Lord, Lawrence Kasherman, et al.
Future Oncology (London, England)|July 30, 2019
Predictive value of PD-L1 and other clinical factors for chemoimmunotherapy in advanced non-small-cell lung cancerRachel Woodford, Yanni Loh, Joanna Lee, et al.
Journal of the American Heart Association|February 18, 2022
Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID StudyMalcolm West, Adrienne Kirby, Ralph A Stewart, et al.
Journal of the American Heart Association|October 25, 2024
Plasma Protein Biomarkers and Long-Term Cardiovascular Mortality Risk in Patients With Chronic Coronary Heart DiseaseRalph A H Stewart, Kristy P Robledo, Andrew M Tonkin, et al.
BMJ Paediatrics Open|February 12, 2025
Targeted oxygenation in the respiratory care of premature infants at delivery-effects on outcome: a randomised controlled trial (Torpido 3060) study protocolJu Lee Oei, Javeed Travadi, Adrienne Kirby, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 28, 2018
The Value of Early Depth of Response in Predicting Long-Term Outcome in EGFR-Mutant Lung CancerChee Khoon Lee, Sally Lord, Ian Marschner, et al.
Diabetes, Obesity & Metabolism|April 4, 2020
Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD studyJacob Y Cao, Boris Waldman, Rachel O'Connell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Serum Human Epidermal Growth Factor 2 Extracellular Domain as a Predictive Biomarker for Lapatinib Treatment Efficacy in Patients With Advanced Breast CancerChee Khoon Lee, Lucy Davies, Val J Gebski, et al.
Pageof 4